Categories: News

iZafe Group Invites Shareholders and Others to a Q&A Session Following The Publishing of The Third Quarter Report

STOCKHOLM, SWEDEN / ACCESSWIRE / November 24, 2021 / iZafe Group (STO:IZAFE-B)

Stockholm, Sweden, iZafe Group AB (publ) (“iZafe” or “the Company”) announces the opportunity for shareholders, media, and other stakeholders to ask company-related questions in connection with its third quarter report. The report will be available to the public on November 29, 2021 at 08:30 (8:30 a.m.) CET.

Questions will be answered by Chief Executive Officer Anders Segerström and published on December 8, 2021 on iZafe Group’s investor site under the heading Financial Reports, Investor Questions.

Please send your questions to ir@izafegroup.com before 10:00 (10 a.m.) CET on December 1, 2021.

Contacts

Carl-Fredrik Bothén, Chief Marketing Officer
E-mail: carl-fredrik.bothen@izafegroup.com
Phone number: +46 73-064 48 67

Anders Segerström, Chief Executive Officer
E-mail: anders.segerstrom@izafegroup.com
Phone number: +46 70-875 14 12

iZafe Group AB (publ.)
Södra Fiskartorpsvägen 20
114 33 Stockholm

E-mail: ir@izafegroup.com
www.izafe.se/investor-relations/

About Us

iZafe Group is a Swedish Life-Science company that develops and markets medical and digital security solutions to create safer drug handling at home. The company’s digital medication dispenser Dosell reduces the risk of incorrect medication, increases security for family and relatives and relieves public care personnel. The products form a holistic concept that facilitates patient medication and gives those who are treated at home better conditions for a happy and safe life. Customers today consist of public and private care providers in Sweden, the Nordic countries and globally. iZafe Group sells primarily through well-established partners who already have long and deep customer relationships with the priority customer groups. The head office is located in Stockholm.

The company is listed on the NASDAQ First North Premier Growth Market. FNCA Sweden AB is the company’s Certified Adviser. Phone: +46 (0) 8 528 00 399. E-mail: info@fnca.se . Further information is available at www.izafe.se/investor-relations/ .

Attachments

iZafe Group invites shareholders and others to a Q&A session following the publishing of the third quarter report

SOURCE: iZafe Group

View source version on accesswire.com:
https://www.accesswire.com/674554/iZafe-Group-Invites-Shareholders-and-Others-to-a-QA-Session-Following-The-Publishing-of-The-Third-Quarter-Report

Staff

Recent Posts

Defence’s Successful Results on Its AccuTOX Anti-Cancer ARM Vaccine Creates a Potent Second-Generation Anti-Cancer ARM-002 Vaccine

Vancouver, British Columbia--(Newsfile Corp. - March 26, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB:…

1 hour ago

Nobul AI Corp and Check-Cap Ltd Enter into Definitive Business Combination Agreement

Proposed business combination to create a North American technology company with an AI-driven fintech marketplace.…

5 hours ago

Dr. Ji Han’s NY Spine Care Offers Cutting-Edge Interventional Pain Management

NEW YORK, NY / ACCESSWIRE / March 25, 2024 / Chronic pain affects millions of…

8 hours ago

FendX Technologies Announces Second Closing of Non-Brokered Private Placement and Announces Further Upsizing to $2 million

Oakville, Ontario--(Newsfile Corp. - March 25, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF)…

11 hours ago

VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update

Conference call to discuss financial and operational results scheduled for Tuesday, March 26 at 8:30…

11 hours ago

Brüush Receives Additional Delisting Notification to Address at Hearing

VANCOUVER, BC / ACCESSWIRE / March 25, 2024 / Bruush Oral Care Inc. (NASDAQ:BRSH) (the…

11 hours ago